State of Wyoming Invests $866,000 in HealthEquity, Inc. $HQY

State of Wyoming bought a new position in HealthEquity, Inc. (NASDAQ:HQY) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 10,367 shares of the company’s stock, valued at approximately $866,000.

A number of other hedge funds also recently made changes to their positions in HQY. Acumen Wealth Advisors LLC purchased a new position in HealthEquity during the 4th quarter valued at approximately $27,000. Caitong International Asset Management Co. Ltd raised its holdings in shares of HealthEquity by 1,723.5% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 310 shares of the company’s stock worth $28,000 after acquiring an additional 293 shares in the last quarter. Aster Capital Management DIFC Ltd bought a new position in shares of HealthEquity during the 4th quarter valued at approximately $28,000. Leonteq Securities AG boosted its position in shares of HealthEquity by 159.9% during the 1st quarter. Leonteq Securities AG now owns 382 shares of the company’s stock valued at $32,000 after acquiring an additional 235 shares during the last quarter. Finally, Torren Management LLC purchased a new position in shares of HealthEquity in the fourth quarter valued at $40,000. 99.55% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on the stock. Weiss Ratings raised shares of HealthEquity from a “hold (c)” rating to a “hold (c+)” rating in a research note on Friday, June 5th. Barrington Research reissued an “outperform” rating and issued a $110.00 price objective on shares of HealthEquity in a research note on Friday, May 22nd. Wall Street Zen downgraded shares of HealthEquity from a “buy” rating to a “hold” rating in a report on Saturday, July 4th. KeyCorp restated an “overweight” rating on shares of HealthEquity in a research report on Tuesday, May 26th. Finally, Citizens Jmp increased their price target on shares of HealthEquity from $110.00 to $111.00 and gave the company a “market outperform” rating in a report on Monday, June 1st. Eleven equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $110.57.

HealthEquity Stock Performance

NASDAQ:HQY opened at $95.95 on Thursday. The firm has a market capitalization of $8.02 billion, a PE ratio of 35.94, a PEG ratio of 1.64 and a beta of 0.21. The stock’s fifty day moving average is $89.72 and its 200 day moving average is $84.85. HealthEquity, Inc. has a fifty-two week low of $72.76 and a fifty-two week high of $105.96. The company has a debt-to-equity ratio of 0.46, a quick ratio of 3.44 and a current ratio of 3.44.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings data on Thursday, May 28th. The company reported $1.24 EPS for the quarter, topping the consensus estimate of $1.11 by $0.13. HealthEquity had a net margin of 17.25% and a return on equity of 14.75%. The company had revenue of $354.64 million during the quarter, compared to analyst estimates of $352.02 million. HealthEquity’s revenue was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. On average, sell-side analysts anticipate that HealthEquity, Inc. will post 3.92 earnings per share for the current year.

Insider Buying and Selling

In related news, EVP Delano Ladd sold 7,500 shares of the stock in a transaction dated Thursday, May 28th. The shares were sold at an average price of $90.00, for a total value of $675,000.00. Following the sale, the executive vice president directly owned 91,141 shares of the company’s stock, valued at $8,202,690. This represents a 7.60% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Michael Henry Fiore sold 3,142 shares of the firm’s stock in a transaction dated Friday, May 29th. The stock was sold at an average price of $95.00, for a total transaction of $298,490.00. Following the completion of the sale, the executive vice president directly owned 59,113 shares of the company’s stock, valued at approximately $5,615,735. The trade was a 5.05% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 17,905 shares of company stock valued at $1,651,280. Company insiders own 1.60% of the company’s stock.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.